From xenobiotic chemistry and metabolism to better prediction and risk assessment of skin allergy

Toxicology

Volumn 192, Issue 1, 2003, Pages 1-22

  Smith Pease, Camilla K ^a  

^a UNILEVER RESEARCH   (United Kingdom)

Author keywords

Allergic contact dermatitis; Protein hapten conjugates; Xenobiotics

Indexed keywords

CINNAMALDEHYDE; CINNAMIC ACID DERIVATIVE; HAPTEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; XENOBIOTIC AGENT;

ANTIGEN RECOGNITION; AUTOOXIDATION; BINDING AFFINITY; BIOAVAILABILITY; CELL ACTIVITY; CELL CULTURE; COMPUTER MODEL; COVALENT BOND; DETOXIFICATION; HUMAN; IN VITRO STUDY; LYMPH NODE; NONHUMAN; PH; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEOMICS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; RISK ASSESSMENT; SKIN ABSORPTION; SKIN ALLERGY; SKIN SENSITIZATION; T LYMPHOCYTE; XENOBIOTIC METABOLISM;

ANIMALIA;

EID: 0141718379     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(03)00246-4     Document Type: Article

References (62)

1. Barratt M.D., Basketter D.A. Possible origin of the sensitisation potential of isoeugenol and related compounds, I. Preliminary studies of potential reaction mechanisms. Contact Dermatitis. 27:1992;98-104.
2. Basketter D.A. Skin sensitisation to cinnamic alcohol: the role of skin metabolism. Acta Derm. Venereol. 72:1992;264-265.
3. Basketter D.A., Gerberick G.F., Kimber I., Willis C. The Toxicology of Contact Dermatitis. 1999;Wiley, Chichester.
4. Basketter D.A., Lea L.J., Cooper K., Dickens A., Briggs D., Pate I., Dearman R.J., Kimber I. A comparison of mathematical approaches to derivation of EC3 values from local lymph node assay dose responses. J. Appl. Toxicol. 19:1999b;261-266.
5. Basketter D.A., Gerberick G.F., Kimber I. Measurement of allergenic potency using the local lymph node assay. Trends Pharmacol. Sci. 22:2001;264-265.
6. Basketter D.A., Gerberick G.F., Kimber I. Skin sensitisation, vehicle effects and the local lymph node assay. Food Chem. Toxicol. 39:(6):2001;621-627.
7. Basketter D.A., Wright Z., Colson N., Patlewicz G., Smith Pease C.K. Investigation of the skin sensitizing activity of linalool. Contact Dermatitis. 47:(3):2002;161-164.
8. Bouvier M., Guo H.C., Smith K.J., Wiley D.C. Crystal structures of HLA-A*0201 complexed with antigenic peptides with either the amino- or carboxyl-terminal group substituted by a methyl group. Proteins. 33:1998;97-106.
9. Branden C., Tooze J. Introduction to protein structure. 1991;Garland Publishing, New York.
10. Buus S. Description and prediction of peptide-MHC binding: the 'human MHC project'. Curr. Opin. Immunol. 11:1999;209-213.
11. Cavani A., Hackett C.J., Wilson K.J., Rothbard J.B., Katz S.I. Characterization of epitopes recognized by hapten-specific CD4+ T cells. J. Immunol. 154:1995;1232-1238.
12. Cheung C., Smith C.K., Hoog J.-O., Hotchkiss S.A.M. Expression and localisation of human alcohol and aldehyde dehydrogenase enzymes in skin. Biochem. Biophys. Res. Commun. 261:1999;100-107.
13. Cheung C., Davies N.G., Hoog J-O., Hotchkiss S.A., Smith Pease C.K. Species variations in cutaneous alcohol dehydrogenases and aldehyde dehydrogenases may impact on toxicological assessments of alcohols and aldehydes. Toxicology. 184:2003a;87-99.
14. Cheung C., Hotchkiss S.A., Pease C.K. Cinnamic compound metabolism in human skin and the role metabolism may play in determining relative sensitisation potency. J. Dermatol. Sci. 31:(1):2003b;9-19.
15. Coombs R.R.A., Gell P.G.H. Classification of allergic reactions for clinical hypersensitivity and disease. Gell P.G.H., Coombs R.R.A., Lachman R. Clinical Aspects of Immunology. 1975;761-781 Blackwell Scientific, London.
16. Dessen A., Lawrence C.M., Cupo S., Zaller D.M., Wiley D.C. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity. 7:1997;473-481.
17. Divkovic M., Basketter D.A., Gilmour N., Dell A., Morris H., Smith Pease C.K. Protein-hapten binding: challenges and limitations. J. Cutaneous & Ocular toxicol. 22:2003;87-99.
18. Dupuis G. Studies on poison ivy. In vitro lymphocyte transformation by urushiol-protein conjugates. Br. J. Dermatol. 101:1979;617-624.
19. Dupuis G., Benezra C. Allergic Contact Dermatitis to Simple Chemicals: A Molecular Approach. 1982;Marcel Dekker, New York.
20. Elahi E. Immunochemical detection of hapten-modified proteins in cinnamaldehyde-treated human skin. Drug Metab. Rev. 32:(Suppl. 1):2000;104.
21. Elahi, E.D., Wright, Z., Hinselwood, D., Hotchkiss, S.A.M., Basketter, D.A., Smith Pease, C.K., 2003. Protein binding and metabolism play roles in influencing the relative skin sensitisation potential of cinnamic compounds. Chem. Res. Toxicol. (submitted).
22. Enk A.H., Katz S.I. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. 89:1992;1398-1402.
23. Gawkrodger D.J. Dermatology: an illustrated colour text. 2nd edition:1997;Churchill Livingstone, New York.
24. Gerberick G.F., Ryan C.A., Kimber I., Dearman R.J., Lea L.J., Basketter D.A. Local lymph node assay validation assessment for regulatory purposes. Am. J. Contact Derm. 11:2000;3-18.
25. Ghosh P., Amaya M., Mellins E., Wiley D.C. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature. 378:1995;457-462.
26. Girolomoni G., Cruz P.D. Jr, Bergstresser P.R. Internalization and acidification of surface HLA-DR molecules by epidermal Langerhans' cells: a paradigm for antigen processing. J. Invest. Dermatol. 94:1990;753-760.
27. Hellerstrom S., Thyresson N., Blohm S.-G., Widmark G. On the nature of eczematogenic component of oxidised delta-3-carotene. J. Invest. Dermatol. 24:1955;217-224.
28. Hunt D.F., Michel H., Dickinson T.A., Shabanowitz J., Cox A.L., Sakaguchi K., Appella E., Grey H.M., Sette A. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science. 256:1992;1817-1820.
29. Hutchings C.V., Shum K.W., Gawkrodger D.J. Occupational contact dermatitis has an appreciable impact on quality of life. Contact Derm. 45:2001;17-20.
30. Johansen J.D., Rastogi S.C., Menne T. Exposure to selected fragrance materials. A case study of fragrance-mix-positive eczema patients. Contact Derm. 34:1996;106-110.
31. Johansen J.D., Andersen K.E., Rastogi S.C., Menne T. Threshold responses in cinnamic-aldehyde-sensitive subjects: results and methodological aspects. Contact Derm. 34:(3):1996;165-171.
32. Jones E.Y. MHC class I and class II structures. Curr. Opin. Immunol. 9:1997;75-79.
33. Karlberg A.-T., Basketter D.A., Goossens A., Lepoittevin J.-P. Regulatory classification of substances oxidised to skin sensitisers on exposure to air. Contact Derm. 40:1999;183-188.
34. Kawakubo Y., Nakamori M., Schopf E., Ohkido M. Acetylator phenotype in patients with p-phenylenediamine allergy. Dermatology. 195:1997;43-45.
35. Kimber I., Cumberbatch M., Dearman R.J., Bhushan M., Griffiths C.E. Cytokines and chemokines in the initiation and regulation of epidermal Langerhans' cell mobilisation. Br. J. Dermatol. 142:2000;401-412.
36. Kimber I., Pichowski J.P., Betts C.J., Cumberbatch M., Basketter D.A., Dearman R.J. Alternative approaches to the identification and charactersiation of chemical allergens. Toxicol. In Vitro. 15:2001;307-331.
37. Kimber I., Basketter D.A., Gerberick G.F., Dearman R.J. Allergic contact dermatitis. Int. Immunopharmacol. 2:2002;201-211.
38. Kleijmeer M.J., Oorschot V.M.J., Geuze H.J. Human resident Langerhans cells display a lysosomal compartment enriched in MHC class II. J. Invest. Dermatol. 103:1994;516-523.
39. Krasteva M., Kehren J., Sayag M., Ducluzeau M.T., Dupuis M., Kantakis J., Nicolas J.F. Contact dermatitis. II. Clinical aspects and diagnosis. Eur. J. Dermatol. 9:1999;144.
40. Landsteiner K., Jacobs J. Studies on the sensitization of animals with simple chemical compounds. J. Exp. Med. 64:1936;625-639.
41. Lechler R. The roles of class I and II molecules of the major histocompatibility complex in T-cell immunity. Lechler R. HLA & Disease. 1994;49-72 Academic Press, London.
42. Lepoittevin J.-P., Basketter D.A., Goosens A., Karlberg A.-T. Allergic Contact Dermatitis. The Molecular Basis. 1997;Springer-Verlag, Germany.
43. Letizia, C.S., Cocchiara, J., Wellington, G.A., Funk, C., Isola, D.A., Api, A.M., 1999. Safety Evaluation of Cinnamaldehyde. Report to the Research Institute for Fragrance Material, August.
44. Letizia, C.S., Cocchiara, J., Wellington, G.A., Funk, C., Isola, D.A., Api, A.M., 1999. Safety Evaluation of Cinnamic Alcohol. Report to the Research Institute for Fragrance Material, July.
45. Lisi P., Hansel K. Is benzoquinone the prohapten in cross-sensitivity among aminobenzene compounds. Contact Derm. 39:1998;304-306.
46. McFarland B.J., Beeson C., Sant A.J. Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes. J. Immunol. 163:1999;3567-3571.
47. Murthy V.L., Stern L.J. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. Structure. 5:1997;1385-1396.
48. Patlewicz G., Basketter D.A., Smith C.K., Hotchkiss S.A.M., Roberts D.W. Skin sensitisation structure activity relationships for aldehydes. Contact Derm. 44:(6):2001;331-336.
49. Perrin D.D., Dempsey B., Serjeant E.P. pKa Prediction for Organic Acids and Bases. 1981;109-126 Chapman and Hall, London.
50. Picardo M., Zompetta C., Grandinetti M., Ameglio F., Santucci B., Faggioni A., Passi S. Paraphenylenediamine, a contact allergen, induces oxidative stress in normal human keratinocytes in culture. Br. J. Dermatol. 134:1996;681-685.
51. Pichler W. Predictive drug allergy testing: an alternative viewpoint. Toxicology. 158:(1-2):2001;31-41.
52. Roberts D.W., Lepoittevin J.-P. Hapten-protein interactions. Lepoittevin J.-P., Basketter D.A., Goossens A., Karlberg A.-T. Allergic Contact Dermatitis: the Molecular Basis. 1998;81-111 Springer-Verlag, Berlin.
53. Rock K.L., Goldberg A.L. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17:1999;739-779.
54. Rousset F., Verda D., Garrigue J.-L., Mariani M., Leclaire J. In vitro prediction of contact sensitivity with human cell lines. Contact Derm. 46: (Suppl 4):2002;6.
55. Sant A.J., Beeson C., McFarland B., Cao J., Ceman S., Bryant P.W., Wu S. Individual hydrogen bonds play a critical role in MHC class II: peptide interactions: implications for the dynamic aspects of class II trafficking and DM-mediated peptide exchange. Immunol. Rev. 172:1999;239-253.
56. Skold M., Borje A., Matura M., Karlberg A.T. Studies on the autoxidation and sensitizing capacity of the fragrance chemical linalool, identifying a linalool hydroperoxide. Contact Derm. 46:(5):2002;267-272.
57. Smith C.K., Hotchkiss S.A.M. Allergic Contact Dermatitis: Chemical and Metabolic Mechanisms. 2001;Taylor & Francis, London.
58. Smith C.K., Moore C.A., Smart A.T.S., Hotchkiss S.A.M. Human skin absorption and metabolism of the contact allergens, cinnamic aldehyde and cinnamic alcohol. Toxicol. Appl. Pharmacol. 168:2000;189-199.
59. Smith C.K., Cheung C., Elahi E., Hotchkiss S.A.M. A high-performance liquid chromatography method for the quantification of non-radiolabelled cinnamic compounds in analytes derived from human skin absorption and metabolism experiments. J. Chromatogr. B Biomed. Sci. Appl. 758:(2):2001; 249-264.
60. Verrier A.C., Schmitt D., Staquet M.J. Fragrance and contact allergens in vitro modulate the HLA-DR and E-cadherin expression on human epidermal Langerhans cells. Int. Arch. Allergy Immunol. 120:1999;56-62.
61. Wulferink M., Dierkes S., Gleichmann E. Cross-sensitization to haptens: formation of common haptenic metabolites, T cell recognition of cryptic peptides, and true T cell cross-reactivity. Eur. J. Immunol. 32:(5):2002;1338-1348.
62. Zarutskie J.A., Sato A.K., Rushe M.M., Chan I.C., Lomakin A., Benedek G.B., Stern L.J. A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding. Biochemistry. 38:1999;5878-5887.